Adequate 0 8 0 8 B-chronic_disease
hematological 9 22 9 22 I-chronic_disease
, 22 23 22 23 I-chronic_disease
hepatic 24 31 24 31 I-chronic_disease
, 31 32 31 32 I-chronic_disease
and 33 36 33 36 I-chronic_disease
renal 37 42 37 42 I-chronic_disease
function 43 51 43 51 I-chronic_disease

Advanced 0 8 52 60 O
stage 9 14 61 66 O
HCC 15 18 67 70 B-cancer
( 19 20 71 72 O
Barcelona 20 29 72 81 B-cancer
Clinic 30 36 82 88 I-cancer
Liver 37 42 89 94 I-cancer
Cancer 43 49 95 101 I-cancer
[ 50 51 102 103 I-cancer
BCLC 51 55 103 107 I-cancer
] 55 56 107 108 I-cancer
Stage 57 62 109 114 O
C 63 64 115 116 O
or 65 67 117 119 O
B 68 69 120 121 O
per 70 73 122 125 O
American 74 82 126 134 B-chronic_disease
Association 83 94 135 146 I-chronic_disease
for 95 98 147 150 I-chronic_disease
the 99 102 151 154 I-chronic_disease
Study 103 108 155 160 I-chronic_disease
of 109 111 161 163 I-chronic_disease
Liver 112 117 164 169 I-chronic_disease
Disease 118 125 170 177 I-chronic_disease
[ 126 127 178 179 I-chronic_disease
AASLD 127 132 179 184 I-chronic_disease
] 132 133 184 185 I-chronic_disease
guidelines 134 144 186 196 O
) 144 145 196 197 O

At 0 2 198 200 O
least 3 8 201 206 O
one 9 12 207 210 B-lower_bound
measurable 13 23 211 221 O
viable 24 30 222 228 O
tumor 31 36 229 234 B-cancer
in 37 39 235 237 I-cancer
the 40 43 238 241 I-cancer
liver 44 49 242 247 I-cancer

Bulky 0 5 248 253 B-cancer
disease 6 13 254 261 I-cancer
patients 14 22 262 270 O

Child 0 5 271 276 B-clinical_variable
- 5 6 276 277 I-clinical_variable
Pugh 6 10 277 281 I-clinical_variable
Class 11 16 282 287 O
A 17 18 288 289 O

Current 0 7 290 297 O
or 8 10 298 300 O
past 11 15 301 305 O
history 16 23 306 313 O
of 24 26 314 316 O
cardiovascular 27 41 317 331 B-chronic_disease
disease 42 49 332 339 I-chronic_disease
( 50 51 340 341 O
e.g 51 54 341 344 O
.. 54 56 344 346 O
past 57 61 347 351 O
history 62 69 352 359 O
of 70 72 360 362 O
myocardial 73 83 363 373 B-chronic_disease
infarction 84 94 374 384 I-chronic_disease
, 94 95 384 385 O
ischemic 96 104 386 394 B-chronic_disease
cardiomyopathy 105 119 395 409 I-chronic_disease
) 119 120 409 410 O

Histological 0 12 411 423 O
diagnosis 13 22 424 433 O
of 23 25 434 436 O
cholangiocarcinoma 26 44 437 455 B-cancer
, 44 45 455 456 O
hepatocholangiocarcinoma 46 70 457 481 B-cancer
, 70 71 481 482 O
fibrolamellar 72 85 483 496 B-cancer
carcinoma 86 95 497 506 I-cancer
and 96 99 507 510 O
hepatoblastoma 100 114 511 525 B-cancer

Histological 0 12 526 538 O
/ 12 13 538 539 O
cytological 13 24 539 550 O
diagnosis 25 34 551 560 O
of 35 37 561 563 O
primary 38 45 564 571 O
HCC 46 49 572 575 B-cancer

History 0 7 576 583 O
of 8 10 584 586 O
moderate 11 19 587 595 O
or 20 22 596 598 O
severe 23 29 599 605 O
ascites 30 37 606 613 B-chronic_disease

History 0 7 614 621 O
of 8 10 622 624 O
severe 11 17 625 631 B-chronic_disease
eczema 18 24 632 638 I-chronic_disease
( 25 26 639 640 O
as 26 28 640 642 O
determined 29 39 643 653 O
by 40 42 654 656 O
the 43 46 657 660 O
Investigator 47 59 661 673 O
) 59 60 673 674 O
requiring 61 70 675 684 O
medical 71 78 685 692 O
treatment 79 88 693 702 O

Known 0 5 703 708 O
significant 6 17 709 720 O
immunodeficiency 18 34 721 737 B-chronic_disease
due 35 38 738 741 O
to 39 41 742 744 O
underlying 42 52 745 755 O
illness 53 60 756 763 O
( 61 62 764 765 O
e.g. 62 66 765 769 O
, 66 67 769 770 O
HIV 68 71 771 774 B-chronic_disease
/ 71 72 774 775 O
AIDS 72 76 775 779 B-chronic_disease
) 76 77 779 780 O

Ongoing 0 7 781 788 O
severe 8 14 789 795 O
inflammatory 15 27 796 808 B-chronic_disease
skin 28 32 809 813 I-chronic_disease
condition 33 42 814 823 I-chronic_disease
( 43 44 824 825 O
as 44 46 825 827 O
determined 47 57 828 838 O
by 58 60 839 841 O
the 61 64 842 845 O
Investigator 65 77 846 858 O
) 77 78 858 859 O
requiring 79 88 860 869 O
medical 89 96 870 877 B-treatment
treatment 97 106 878 887 I-treatment

Performance 0 11 888 899 O
status 12 18 900 906 O
0 19 20 907 908 B-lower_bound
or 21 23 909 911 O
1 24 25 912 913 B-upper_bound
on 26 28 914 916 O
the 29 32 917 920 O
Eastern 33 40 921 928 B-treatment
Cooperative 41 52 929 940 I-treatment
Oncology 53 61 941 949 I-treatment
Group 62 67 950 955 I-treatment
( 68 69 956 957 I-treatment
ECOG 69 73 957 961 I-treatment
) 73 74 961 962 I-treatment
scale 75 80 963 968 I-treatment

Symptomatic 0 11 969 980 O
cardiovascular 12 26 981 995 B-chronic_disease
disease 27 34 996 1003 I-chronic_disease

bleeding 0 8 1004 1012 B-chronic_disease
esophageal 9 19 1013 1023 I-chronic_disease
varices 20 27 1024 1031 I-chronic_disease

congestive 0 10 1032 1042 B-chronic_disease
heart 11 16 1043 1048 I-chronic_disease
failure 17 24 1049 1056 I-chronic_disease
within 25 31 1057 1063 O
the 32 35 1064 1067 O
preceding 36 45 1068 1077 B-upper_bound
12 46 48 1078 1080 I-upper_bound
months 49 55 1081 1087 I-upper_bound

hepatic 0 7 1088 1095 B-chronic_disease
encephalopathy 8 22 1096 1110 I-chronic_disease

immune 0 6 1111 1117 B-treatment
- 6 7 1117 1118 I-treatment
suppressive 7 18 1118 1129 I-treatment
medication 19 29 1130 1140 I-treatment
including 30 39 1141 1150 O
high 40 44 1151 1155 O
- 44 45 1155 1156 O
dose 45 49 1156 1160 O
corticosteroids 50 65 1161 1176 B-treatment

pleural 0 7 1177 1184 B-chronic_disease
effusions 8 17 1185 1194 I-chronic_disease
related 18 25 1195 1202 O
to 26 28 1203 1205 O
liver 29 34 1206 1211 B-chronic_disease
insufficiency 35 48 1212 1225 I-chronic_disease
within 49 55 1226 1232 O
6 56 57 1233 1234 B-upper_bound
months 58 64 1235 1241 I-upper_bound
of 65 67 1242 1244 O
screening 68 77 1245 1254 O

significant 0 11 1255 1266 B-chronic_disease
coronary 12 20 1267 1275 I-chronic_disease
artery 21 27 1276 1282 I-chronic_disease
disease 28 35 1283 1290 I-chronic_disease
( 36 37 1291 1292 O
e.g. 37 41 1292 1296 O
, 41 42 1296 1297 O
requiring 43 52 1298 1307 O
angioplasty 53 64 1308 1319 B-treatment
or 65 67 1320 1322 O
stenting 68 76 1323 1331 B-treatment
) 76 77 1331 1332 O

tumors 0 6 1333 1339 B-clinical_variable
encompassing 7 19 1340 1352 I-clinical_variable
> 20 21 1353 1354 O
50 21 23 1354 1356 B-lower_bound
% 23 24 1356 1357 I-lower_bound
of 25 27 1358 1360 O
the 28 31 1361 1364 O
liver 32 37 1365 1370 O
volume 38 44 1371 1377 O
and 45 48 1378 1381 O
/ 49 50 1382 1383 O
or 51 53 1384 1386 O
inferior 54 62 1387 1395 B-treatment
vena 63 67 1396 1400 I-treatment
cava 68 72 1401 1405 I-treatment
invasion 73 81 1406 1414 I-treatment

using 0 5 1415 1420 O
a 6 7 1421 1422 O
dynamic 8 15 1423 1430 O
imaging 16 23 1431 1438 O
technique 24 33 1439 1448 O
( 34 35 1449 1450 O
arterial 35 43 1450 1458 B-treatment
phase 44 49 1459 1464 I-treatment
of 50 52 1465 1467 I-treatment
triphasic 53 62 1468 1477 I-treatment
computerized 63 75 1478 1490 I-treatment
tomography 76 86 1491 1501 I-treatment
[ 87 88 1502 1503 I-treatment
CT 88 90 1503 1505 I-treatment
] 90 91 1505 1506 I-treatment
scan 92 96 1507 1511 I-treatment
, 96 97 1511 1512 O
or 98 100 1513 1515 O
dynamic 101 108 1516 1523 B-treatment
contrast 109 117 1524 1532 I-treatment
- 117 118 1532 1533 I-treatment
enhanced 118 126 1533 1541 I-treatment
magnetic 127 135 1542 1550 I-treatment
resonance 136 145 1551 1560 I-treatment
imaging 146 153 1561 1568 I-treatment
[ 154 155 1569 1570 I-treatment
MRI 155 158 1570 1573 I-treatment
] 158 159 1573 1574 I-treatment
) 159 160 1574 1575 O
, 160 161 1575 1576 O
and 162 165 1577 1580 O
injectable 166 176 1581 1591 O
under 177 182 1592 1597 O
imaging 183 190 1598 1605 O
- 190 191 1605 1606 O
guidance 191 199 1606 1614 O
( 200 201 1615 1616 O
CT 201 203 1616 1618 O
and/or 204 210 1619 1625 O
ultrasound 211 221 1626 1636 B-treatment
) 221 222 1636 1637 O

â‰¥1 0 2 1638 1640 O
cm 3 5 1641 1643 I-lower_bound
longest 6 13 1644 1651 I-lower_bound
diameter 14 22 1652 1660 I-lower_bound
( 23 24 1661 1662 I-lower_bound
LD 24 26 1662 1664 I-lower_bound
) 26 27 1664 1665 I-lower_bound

